Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2193-2199, June 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, W.
Right arrow Articles by Bertino, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, W.
Right arrow Articles by Bertino, J. R.

Overexpression of p21waf1 Leads to Increased Inhibition of E2F-1 Phosphorylation and Sensitivity to Anticancer Drugs in Retinoblastoma-negative Human Sarcoma Cells1

WeiWei Li, Jianguo Fan, Daniel Hochhauser and Joseph R. Bertino2

Laboratory of Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The effect of overexpression of p21waf1 on drug sensitivity was studied in an osteosarcoma cell line (SaOs-2) lacking both p53 and functional retinoblastoma protein using a tetracycline (TC)-inducible expression system. p21waf1 expression was barely detectable in SaOS-2 cells incubated in the presence of TC. After TC withdrawal, high levels of p21waf1 were induced in these cells. These p21waf1-induced cells showed increased sensitivity to doxorubicin, tomudex, and methotrexate as compared to uninduced cells; this condition is associated with increased apoptosis. Expression of p21waf1 reduced cyclin A-associated kinase activity and, surprisingly, resulted in inhibition of phosphorylation of E2F-1 and increased E2F-1 binding activity. An S-G2 cell cycle arrest/delay and an increase in expression of E2F-responsive genes (dihydrofolate reductase and thymidylate synthase) was correspondingly observed. Overexpression of p21waf1 in cells lacking functional retinoblastoma protein may mediate sensitivity to anticancer drugs by inhibiting E2F-1 phosphorylation, which may contribute to increased S-G2 cell cycle delay and increased cell susceptibility to apoptosis.

1 Supported by Grant CA47179.

2 To whom requests for reprints should be addressed. Fax: (212) 639-2767.

Received 12/ 2/96. Accepted 4/ 3/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. I. Geller, K. Szekely-Szucs, I. Petak, B. Doyle, and J. A. Houghton
P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells
Cancer Res., September 1, 2004; 64(17): 6296 - 6303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Nowak, P. M. Price, and R. G. Schnellmann
Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F440 - F450.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
W. Li and J. R. Bertino
Fas-mediated Signaling Enhances Sensitivity of Human Soft Tissue Sarcoma Cells to Anticancer Drugs by Activation of p38 Kinase
Mol. Cancer Ther., December 1, 2002; 1(14): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Park, I. Lee, and W. K. Kang
Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death
Carcinogenesis, October 1, 2001; 22(10): 1727 - 1731.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Li, J. Fan, and J. R. Bertino
Selective Sensitization of Retinoblastoma Protein-deficient Sarcoma Cells to Doxorubicin by Flavopiridol-mediated Inhibition of Cyclin-dependent Kinase 2 Kinase Activity
Cancer Res., March 1, 2001; 61(6): 2579 - 2582.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y. Zhang, A. K. Rishi, M. I. Dawson, R. Tschang, L. Farhana, M. Boyanapalli, U. Reichert, B. Shroot, E. C. Van Buren, and J. A. Fontana
S-phase Arrest and Apoptosis Induced in Normal Mammary Epithelial Cells by a Novel Retinoid
Cancer Res., April 1, 2000; 60(7): 2025 - 2032.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
J. A. McKay, J. J. Douglas, V. G. Ross, S. Curran, F. Y. Ahmed, J. F. Loane, G. I. Murray, and H. L. McLeod
Expression of Cell Cycle Control Proteins in Primary Colorectal Tumors Does Not Always Predict Expression in Lymph Node Metastases
Clin. Cancer Res., March 1, 2000; 6(3): 1113 - 1118.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Mueller, E. Cadenas, and A. H. Schönthal
p21WAF1 Regulates Anchorage-independent Growth of HCT116 Colon Carcinoma Cells via E-Cadherin Expression
Cancer Res., January 1, 2000; 60(1): 156 - 163.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
W. Li, J. Fan, D. Banerjee, and J. R. Bertino
Overexpression of p21waf1 Decreases G2-M Arrest and Apoptosis Induced by Paclitaxel in Human Sarcoma Cells Lacking Both p53 and Functional Rb Protein
Mol. Pharmacol., June 1, 1999; 55(6): 1088 - 1093.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Z. Wang, G. Van Tuyle, D. Conrad, P. B. Fisher, P. Dent, and S. Grant
Dysregulation of the Cyclin-dependent Kinase Inhibitor p21 WAF1/CIP1/MDA6 Increases the Susceptibility of Human Leukemia Cells (U937) to 1-{beta}-D-Arabinofuranosylcytosine-mediated Mitochondrial Dysfunction and Apoptosis
Cancer Res., March 1, 1999; 59(6): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Guo, J. H. Healey, P. A. Meyers, M. Ladanyi, A. G. Huvos, J. R. Bertino, and R. Gorlick
Mechanisms of Methotrexate Resistance in Osteosarcoma
Clin. Cancer Res., March 1, 1999; 5(3): 621 - 627.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.